SEC Form 4 · accession 0001209191-17-061004
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kamalam Unninayar
Officer — Chief Financial Officer
Period of report
Nov 15, 2017
Accepted (ET)
Nov 15, 2017 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.07 | Nov 15, 2017 | A | 190,000 | A | — | Nov 14, 2027 | Common Stock | 190,000 | 190,000 | D |
Explanation of responses
- F1This option vests over four years. Twenty-five percent (25%) of the shares will vest on November 15, 2018 and 6.25% of the shares will vest at the end of each successive three month period thereafter.